Hemoperfusion through Amberlite XAD-4 resin column has been shown to effectively remove sedative-hypnotics, analgesics and other drugs causing acute intoxication. There is no appreciable clinical toxicity and dramatic shortening of coma time and possible decrease in mortality may be achieved. Thrombocytopenia and clotting may be diminished by pre-perfusion coating with 2.5% albumin. Albumin coating may facilitate the repeated use of hemoperfusion without any complications. More recently, resin hemoperfusion has been used for procainamide, N-acetylprocainamide and theophylline intoxication achieving exceptionally high clearance rates.
YatizidisH., OreopoulosD., TriantaphyllidisD., VoudiclariS., TsarapesN., GavrasD., StavroulakeA.Treatment of severe barbiturate poisoning.Lancet1965; 2: 216–217.
2.
ChangT.M.S., MaleveN.The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney.Trans Am Soc Artif Intern Organs1970; 16: 141–148.
3.
RosenbaumJ.L., WinstonS., KramerM.S., MorosJ., RajaR.Resin hemoperfusion in the treatment of drug intoxication.Trans Am Soc Artif Intern Organs1970, 16: 134–140.
4.
RosenbaumJ.L., KramerM.S., RajaR., BoreykoC.Resin hemoperfusion: A new treatment for acute drug intoxication.N Engl J Med1971; 284, 874–877.
5.
RosenbaumJ.L., KramerM.S., RajaR.Resin hemoperfusion for acute drug intoxication.Arch Intern Med1976; 136: 263–266.
6.
RosenbaumJ.L., RajaR.Hemoperfusion in acute intoxication. In: The past, present and future of Artif Organs, 128–139, (Meteksan, Ankara) 1983.
7.
TraffordJ.A.P., JonesR.H., EvansR., SharpP., Sharp-stoneP., CookJ.Haemoperfusion with R-004 amberlite resin for treating acute poisoning.Br Med J1977; 2: 1453–1456.
8.
SmileyJ., MarchN., DelGuercioE.T.Hemoperfusion in the managent of digoxin toxicity.JAMA1978; 240: 2736–2737.
9.
GarellaS., LorchJ.A.Hemoperfusion for acute intoxication.Clin Toxicol1980; 17: 583–602.
10.
HampelG., WisemanH., WiddopB.Acute poisoning due to hypnotics: The role of hemoperfusion in clinical perspective.Vet Hum Toxicol1979; 21(suppl), 4.
11.
UldallP.R.Controlled trial of resin hemoperfusion for the treatment of drug overdoses at Toronto Western Hospital.Trans Am Soc Artif Organs1982; 28: 676–677.
12.
GibsonT.P., NelsonH.A., IvanovichP.Digoxin removal from an anephric patient by hemoperfusion over XAD-4.Artif Organs1978; 2: 393–401.
13.
HoyW., GibsonT.P., BiddleT.Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin.Artif Organs1979; 3: 124.
14.
VlassersP.H., FergusonR.K., RocciM.L.Jr., RajaR.M., PorterR.S., GreenspanA.M.Lethal accumulation of procainamide metabolite in severe renal insufficiency.Am J Nephrol1986; 6: 112–116.
15.
RajaR., KramerM., AlvisR., GoldsteinS., De Los AngelesA.: Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.Trans Am Soc Artif Int Organs1984; 30: 18–20.
16.
ParkA.D., SpectorR., RobertR.J., GoldbergM.J., WeismanD., StillermanA., FlaniganM.J.Use of hemoperfusion for treatment of theophylline intoxication.Am J Med1983; 74: 961–966.
17.
BibersteinM.P., ZeiglerM.G., WardD.M.Use of B blockade and hemoperfusion for acute Theophylline poisoning.West J Med1984; 141: 485–490.
18.
FalkenhagenD., GottschallS., EstherG., CourtneyJ.M., KlinkmanH.In vitro assessment of charcoal and resin hemoperfusion. In: Hemoperfusion, 23–33, (Karger, Basel) 1982.
19.
BarberK., ChenS.M., FergusonR., KramerM.S., RajaR.M.Lidocaine removal during resin hemoperfusion for phenobarbital intoxication.Artif Organs1984; 8: 229–231.
